Aortic mural thrombosis with bilateral renal infarction in a woman taking dienogest for adenomyosis: A case report and literature review
review
OA: gold
CC-BY-NC-ND-4.0
AI-generated summary
This case report describes a woman with adenomyosis and antiphospholipid syndrome who developed aortic mural thrombosis and bilateral renal infarction after taking dienogest, highlighting a potential progestin-induced thrombosis risk.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: We presented a rare case of aortic mural thrombosis with bilateral renal infarction in a woman taking dienogest for adenomyosis. The objective is to highlight the possible risk of thrombosis in woman with antiphospholipid syndrome taking progestin-only contraceptives for endometriosis.
CASE REPORT: We presented a 48-year-old woman who has adenomyosis for years. After using dienogest for 1 month, she experienced severe abdominal pain and was diagnosed to have dienogest-induced aortic mural thrombosis and bilateral renal infarction. Successful treatment was achieved with the use of heparin followed by edoxaban. Intriguingly, the patient was diagnosed to have antiphospholipid syndrome 4 months later. The patient remained under regular follow-up for two years, during which no further thrombotic episodes were noted.
CONCLUSION: Progestin-only contraceptives may be an acceptable choice for patients with adenomyosis and antiphospholipid syndrome, the risk of thrombosis should still be kept in mind.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-06-29T06:08:12.325296+00:00
- pubmed
- last seen: 2026-06-29T06:04:34.422132+00:00
- unpaywall
- last seen: 2026-05-11T08:34:28.763810+00:00
License: CC-BY-NC-ND-4.0
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine